Clevipidine recalls

The FDA has published 1 recall involving Clevipidine since 2026. The latest was reported on 22 Jul 2026. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2026

Last 12 months1reported

Class I00% of total

Ongoing1latest 22 Jul 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 1 0Aug 0 0

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why clevipidine is recalled

Sterility1100%

Companies

Chiesi USA1100%

By year

20261100%

Ongoing clevipidine recalls

1 active

Reported	Class	Recall	Company	Reason	Where
22 Jul 2026Drug	CLASS II	Cleviprex (clevidipine injectable emulsion) 50 mg recalled by Chiesi USACleviprex	Chiesi USA	Sterility	Nationwide

All clevipidine recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
22 Jul 2026Drug	CLASS II	Cleviprex (clevidipine injectable emulsion) 50 mg recalled by Chiesi USACleviprex	Chiesi USA	Sterility	Nationwide

Should you stop taking Clevipidine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.